AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- The FDA said Friday it will offer ultra-fast review to three psychedelic drugs being developed for hard-to-treat forms of depression and post-traumatic stress disorder (PTSD), the latest step by the Trump administration toward...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- U.S. data from the past decade warned that a growing number of babies who miss their hepatitis B vaccine at birth may never get fully vaccinated. Among 210,000 children who missed their birth dose, 73.2% of those born in 2014...
(MedPage Today) -- The first interim safety results from a multicenter, safety surveillance study of Alzheimer's disease patients treated with lecanemab (Leqembi) in real-world clinical practice were consistent with the known safety profile of...
(MedPage Today) -- Cardiovascular protection with GLP-1 receptor agonists may benefit patients undergoing certain transcatheter procedures, according to two observational studies. When used as an adjunct to transcatheter aortic valve replacement...
(MedPage Today) -- The investigational cell therapy deramiocel slowed upper limb functional decline in boys and young men with Duchenne muscular dystrophy, data from the phase III HOPE-3 trial showed. At 12 months, the mean percent change from...
